Retatrutide 30mg
One of the most talked-about compounds in metabolic research — currently in active Phase III clinical trials. Studied for its triple-receptor mechanism across GLP-1, GIP, and glucagon pathways with documented body composition outcomes in published trial data.
GLP-1/GIP/GlucagonTriple AgonistPhase II/III
1-2x — $903x — $875x — $77 ✦
Details & References →